Skip to main content
Evionnaz

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland. The company is investing up to €23 million at the facility, which will begin operations in 2024 and host about 100 scientists, working alongside another R&D centre at the main site in Zofingen. The centre will host advanced chemical and analytical facilities and laboratories, offering chemical process R&D and analytical development services for the entire drug substances network, Siegfried said.

Add new comment

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.